期刊文献+

Medical management of erectile dysfunction in aging males: is it too late to treat?

Medical management of erectile dysfunction in aging males: is it too late to treat?
下载PDF
导出
摘要 Erectile dysfunction (ED) is a common disorder among aging males. However, most aging males refuse to seek medical help and believe that ED is an irreversible event in the aging process. The purpose of this study was to describe the current medical management of ED in aging males and to examine whether it is too late to treat this disorder in these elderly men. From 2007 to 2008, 4507 patients diagnosed with ED were gathered from 46 centers in China; 4241 completed the study, 3837 of whom were treated with sildenafil. The 3837 patients were divided into five groups based on age (group A: 20-30 years; group B: 31-40 years; group C: 41-50 years; group D: 51-60 years; and group E: 〉60 years). After comparing pre- and posttreatment International Index of Erectile Function-Erectile Function domain (IIEF-EF) questionnaires, Erection Hardness Scale (EHS), and IIEF Q13 ("How satisfied have you been with your overall sex life?"), we discovered that the aging males had worse erectile function, erection hardness, and sexual satisfaction than the younger males (P〈 0.001). After treatment, the improvement rates in the IIEF-EF, EHS, and IIEF Q13 scores were 107.0%, 83.1%, and 116.5%, respectively. The magnitude of these changes demonstrated significant differences among groups (P 〈 0.001). Accordingly, aging males are likely to benefit more from medical treatment. We propose that aging males should be informed that age is not a limiting factor for medical ED management, and it is never too late to treat. Erectile dysfunction (ED) is a common disorder among aging males. However, most aging males refuse to seek medical help and believe that ED is an irreversible event in the aging process. The purpose of this study was to describe the current medical management of ED in aging males and to examine whether it is too late to treat this disorder in these elderly men. From 2007 to 2008, 4507 patients diagnosed with ED were gathered from 46 centers in China; 4241 completed the study, 3837 of whom were treated with sildenafil. The 3837 patients were divided into five groups based on age (group A: 20-30 years; group B: 31-40 years; group C: 41-50 years; group D: 51-60 years; and group E: 〉60 years). After comparing pre- and posttreatment International Index of Erectile Function-Erectile Function domain (IIEF-EF) questionnaires, Erection Hardness Scale (EHS), and IIEF Q13 ("How satisfied have you been with your overall sex life?"), we discovered that the aging males had worse erectile function, erection hardness, and sexual satisfaction than the younger males (P〈 0.001). After treatment, the improvement rates in the IIEF-EF, EHS, and IIEF Q13 scores were 107.0%, 83.1%, and 116.5%, respectively. The magnitude of these changes demonstrated significant differences among groups (P 〈 0.001). Accordingly, aging males are likely to benefit more from medical treatment. We propose that aging males should be informed that age is not a limiting factor for medical ED management, and it is never too late to treat.
出处 《Asian Journal of Andrology》 SCIE CAS CSCD 2014年第1期153-156,共4页 亚洲男性学杂志(英文版)
关键词 aging males erectile dysfunction international index of erectile dysfunction (IIEF) SILDENAFIL SEX aging males erectile dysfunction international index of erectile dysfunction (IIEF) sildenafil sex
  • 相关文献

参考文献5

二级参考文献37

  • 1QuanBai,Qing-QuanXu,HuiJiang,Wei-LiZhang,Xing-HuanWang,Ji-ChuanZhu.Prevalence and risk factors of erectile dysfunction in three cities of China: a community-based study[J].Asian Journal of Andrology,2004,6(4):343-348. 被引量:25
  • 2Wai Chun Andrew Yip,Han-Sun Chiang,Jesus Benjamin Mendoza,Hui-Meng Tan,Man-Kay Li,Wei Christine Wang,Vladimir Kopernicky.Efficacy and safety of on demand tadalafil in the treatment of East and Southeast Asian men with erectile dysfunction:a randomized double-blind,parallel,placebo-controlled clinical study[J].Asian Journal of Andrology,2006,8(6):685-692. 被引量:6
  • 3Tsertsvadze A, Yazdi F, Fink HA, MacDonald R, Wilt TJ et al. Oral sildenafil citrate (viagra) for erectile dysfunction: a systematic review and meta-analysis of harms. Urology 2009; 74:831-6.
  • 4Langtry HD, Markham A. Sildenafil: a review of its use in erectile dysfunction. Drugs 1999; 57: 967-89.
  • 5Kongkanand A, Ratana-Olarn K, Ruangdilokrat S, Tantiwong A. The efficacy and safety of oral sildenafil in Thai men with erectile dysfunction: a randomized, double-blind, placebo controlled, flexible-dose study. J Med Assoc Thai 2003; 86: 195-205.
  • 6Kongkanand A. Prevalence of erectile Dysfunction Epidemiological Study Group dysfunction in Thailand. Thai Erectile Int J Androl 2000; 23 (Suppl 2): 77-80.
  • 7An epidemiological study of erectile dysfunction in Thailand (Part 1 : Prevalence). Thai Erectile Dysfunction Epidemiologic Study Group (TEDES). J MedAssoc Thai 2000; 83: 872-9.
  • 8Permpongkosol S, Kongkakand A, Ratana-Olarn K, Tantiwong A, Tantiwongse K. increased prevalence of erectile dysfunction (ED): results of the second epidemiological study on sexual activity and prevalence of ED in Thai males. Aging Male 2008; 11: 128-33.
  • 9Guadamuz TE, Kunawararak P, Beyrer C, Pumpaisanchai J, Wei C et al. HIV prevalence, sexual and behavioral correlates among Shah, Hill tribe, and Thai male sex workers in Northern Thailand. AIDS Care 2010; 22:597-605.
  • 10Ford K, Chamratrithirong A. First sexual experience and current sexual behaviour among older Thai men and women. Sex Health 2009; 6: 195-202.

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部